An intact NF-κB signaling pathway is required for maintenance of mature B cell subsets

被引:57
作者
Bendall, HH
Sikes, ML
Ballard, DW
Oltz, EM
机构
[1] Vanderbilt Univ, Sch Med, Dept Microbiol & Immunol, Nashville, TN 37232 USA
[2] Vanderbilt Univ, Sch Med, Howard Hughes Med Inst, Nashville, TN 37232 USA
关键词
NF-kappa B/Rel transcription factors; B cell development; B cell homeostasis; B cell receptor signaling; transgenic mice;
D O I
10.1016/S0161-5890(99)00031-0
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Members of the NF-kappa B/Rel transcription factor family are expressed constitutively during B cell development and are further induced by mitogen activation. Mice harboring germline disruptions in individual NF-kappa B subunits exhibit distinct defects in B lymphocyte activation and survival. However, the role of NF-kappa B in the production and maintenance of B cell subsets has been difficult to dissect in these knockout animals due to functional impairment of other immune cells. To directly address the cell autonomous requirements for NF-kappa B in humoral immune compartments, transgenic mice were generated that express a trans-dominant form of I kappa B alpha in B lineage cells. Whereas expression of the inhibitor had only modest effects on basal or LPS-induced levels of NF-kappa B, transgenic B cells were significantly impaired for cellular proliferation and NF-kappa B induction in response to B cell receptor (BCR) crosslinking. Furthermore, the trans-dominant inhibitor produced a dose-dependent reduction in the population of mature splenic B cells. This cellular defect was more pronounced in long-lived B lymphocyte subsets that recirculate to the adult bone marrow. Together, these results indicate that BCR-mediated signaling must maintain NF-kappa B levels above a stringent threshold for proper regulation of B cell homeostasis. (C) 1999 Elsevier Science Ltd. All rights reserved.
引用
收藏
页码:187 / 195
页数:9
相关论文
共 33 条
[1]   NF-kappa B: Ten years after [J].
Baeuerle, PA ;
Baltimore, D .
CELL, 1996, 87 (01) :13-20
[2]   The NF-kappa B and I kappa B proteins: New discoveries and insights [J].
Baldwin, AS .
ANNUAL REVIEW OF IMMUNOLOGY, 1996, 14 :649-683
[3]   THE V-REL ONCOGENE ENCODES A KAPPA-B ENHANCER BINDING-PROTEIN THAT INHIBITS NF-KAPPA-B FUNCTION [J].
BALLARD, DW ;
WALKER, WH ;
DOERRE, S ;
SISTA, P ;
MOLITOR, JA ;
DIXON, EP ;
PEFFER, NJ ;
HANNINK, M ;
GREENE, WC .
CELL, 1990, 63 (04) :803-814
[4]   Transcription factor NF-kappa B regulates inducible Oct-2 gene expression in precursor B lymphocytes [J].
Bendall, HH ;
Scherer, DC ;
Edson, CR ;
Ballard, DW ;
Oltz, EM .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (46) :28826-28828
[5]  
BOOTHBY M, 1989, J IMMUNOL, V142, P1005
[6]   Perturbation of the T lymphocyte lineage in transgenic mice expressing a constitutive repressor of nuclear factor (NF)-kappa B [J].
Boothby, MR ;
Mora, AL ;
Scherer, DC ;
Brockman, JA ;
Ballard, DW .
JOURNAL OF EXPERIMENTAL MEDICINE, 1997, 185 (11) :1897-1907
[7]  
BROCKMAN JA, 1995, MOL CELL BIOL, V15, P2809
[8]   Inhibition of NF-κB activity results in disruption of the apical ectodermal ridge and aberrant limb morphogenesis [J].
Bushdid, PB ;
Brantley, DM ;
Yull, FE ;
Blaeuer, GL ;
Hoffman, LH ;
Niswander, L ;
Kerr, LD .
NATURE, 1998, 392 (6676) :615-618
[9]   SIGNAL-INDUCED SITE-SPECIFIC PHOSPHORYLATION TARGETS I-KAPPA-B-ALPHA TO THE UBIQUITIN-PROTEASOME PATHWAY [J].
CHEN, ZJ ;
HAGLER, J ;
PALOMBELLA, VJ ;
MELANDRI, F ;
SCHERER, D ;
BALLARD, D ;
MANIATIS, T .
GENES & DEVELOPMENT, 1995, 9 (13) :1586-1597
[10]   Suppression of tumor necrosis factor-induced cell death by inhibitor of apoptosis c-IAP2 is under NF-kappa B control [J].
Chu, ZL ;
McKinsey, TA ;
Liu, L ;
Gentry, JJ ;
Malim, MH ;
Ballard, DW .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1997, 94 (19) :10057-10062